Liaoning Cracks Down on Illicit Substances, Focuses on Youth Prevention
Hızlı Bakış
- Liaoning Province intensifies efforts against illicit substances like "head-hitting" e-cigarettes and nitrous oxide, arresting 391 suspects and penalizing 5,164 users.
- The province also strengthens drug regulation and family-based prevention campaigns.
Yapay zekâ özeti
Neden Önemli?
Liaoning Province is holding a press conference to address concerns regarding the abuse of unlisted addictive substances like "head-hitting" e-cigarettes and nitrous oxide. The province is implementing a multi-pronged approach involving law enforcement, drug regulation, and family education.
中新网沈阳6月3日电(记者王景巍)6月3日,在辽宁省政府新闻办举行的发布会上,辽宁省禁毒委副主任、省公安厅反恐专员朱朝键,省禁毒委委员、省药监局副局长王嘉仡,省禁毒委委员、辽宁省妇联副主席吴文彩,辽宁省公安厅禁毒总队总队长陈旭出席并答记者问,从打击整治、药品监管、家庭宣教三个维度回应社会关切。
针对“上头电子烟”“笑气”等未列管成瘾性物质滥用蔓延态势,辽宁公安禁毒部门已连续两年发起专项打击。朱朝键介绍,辽宁省形成禁毒部门牵头、全警参战的"研、查、打"一体化打击模式,今年以来共抓获涉未列管物质犯罪嫌疑人391人,查处滥用人员5164人。
防范青少年药物滥用,管好麻精药品是关键一环。据王嘉仡介绍,辽宁省药监局坚持“管得住、用得上”原则,以安全管理零缺陷为标准,严格购用审批和计划核定。
在日常监管方面,2026年已完成麻精药品定点生产经营企业监督检查67家次、零售药店飞行检查112家次。同时建立购销异常处置制度,重点关注乡村诊所、学校及娱乐场所周边医疗机构购用情况,今年已筛查预警信息85条,全力让“监管跑在风险前面”。
家庭是禁毒工作的最小单元,也是第一道防线。吴文彩介绍,辽宁省各级妇联以“不让毒品进我家”活动为主线,累计开展专题讲座、亲子学堂、情景模拟等禁毒宣传活动1.1万余场,覆盖妇女及家庭成员49万余人。
线上依托“巾帼秀辽宁”微信公众号等平台推送禁毒知识,制作发布微课堂、动漫短视频,参与学习超1万人次;线下将禁毒宣传融入"巾帼红"女子半马等活动,实现“体育+普法”跨界传播。联合省禁毒办印发《致全省广大姐妹及家庭的禁毒倡议书》2万份,开展“同心护家·共筑无毒”家庭防毒专场活动。
吴文彩表示,下一步将重点做好家庭阵地精准防毒宣传、基层妇联禁毒业务赋能培训、涉毒家庭及留守儿童关爱帮扶三项工作,推动禁毒工作与社会救助、家庭教育、平安建设深度融合。(完)
Bundan Sonra Ne Olabilir?
Yapay zekâ öngörüsü — kesinlik taşımaz
Continued focus on family-based prevention and grassroots empowerment for women's federations.
Çok muhtemel · Orta vadede
Further integration of drug control efforts with social assistance, family education, and peace-building initiatives.
Çok muhtemel · Orta vadede
Açık Sorular
- What specific unlisted addictive substances are most prevalent in Liaoning?
- What are the long-term strategies for preventing youth drug abuse?
- How effective have the 'sports + legal education' initiatives been?
- What are the specific challenges in regulating psychotropic drugs?






